A Phase II clinical trial of BMS-247550 (NSC 710428), an epothilone B analog, in patients with breast carcinoma.
Phase of Trial: Phase II
Latest Information Update: 19 Jun 2013
At a glance
- Drugs Ixabepilone (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 30 Jul 2007 Status changed from in progress to completed
- 30 Aug 2005 New trial record.